Historical Valuation
Fulgent Genetics Inc (FLGT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.27 is considered Undervalued compared with the five-year average of -37.20. The fair price of Fulgent Genetics Inc (FLGT) is between 28.30 to 50.02 according to relative valuation methord. Compared to the current price of 27.85 USD , Fulgent Genetics Inc is Undervalued By 1.6%.
Relative Value
Fair Zone
28.30-50.02
Current Price：27.85
1.6%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Fulgent Genetics Inc (FLGT) has a current Price-to-Book (P/B) ratio of 0.70. Compared to its 3-year average P/B ratio of 0.63 , the current P/B ratio is approximately 10.67% higher. Relative to its 5-year average P/B ratio of 1.29, the current P/B ratio is about -45.80% higher. Fulgent Genetics Inc (FLGT) has a Forward Free Cash Flow (FCF) yield of approximately -2.51%. Compared to its 3-year average FCF yield of 1.14%, the current FCF yield is approximately -319.80% lower. Relative to its 5-year average FCF yield of 9.08% , the current FCF yield is about -127.65% lower.
P/B
Median3y
0.63
Median5y
1.29
FCF Yield
Median3y
1.14
Median5y
9.08
Competitors Valuation Multiple
AI Analysis for FLGT
The average P/S ratio for FLGT competitors is 2.83, providing a benchmark for relative valuation. Fulgent Genetics Inc Corp (FLGT.O) exhibits a P/S ratio of 2.27, which is -19.91% above the industry average. Given its robust revenue growth of 17.18%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for FLGT
1Y
3Y
5Y
Market capitalization of FLGT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of FLGT in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is FLGT currently overvalued or undervalued?
Fulgent Genetics Inc (FLGT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.27 is considered Undervalued compared with the five-year average of -37.20. The fair price of Fulgent Genetics Inc (FLGT) is between 28.30 to 50.02 according to relative valuation methord. Compared to the current price of 27.85 USD , Fulgent Genetics Inc is Undervalued By 1.60% .
What is Fulgent Genetics Inc (FLGT) fair value?
FLGT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Fulgent Genetics Inc (FLGT) is between 28.30 to 50.02 according to relative valuation methord.
How does FLGT's valuation metrics compare to the industry average?
The average P/S ratio for FLGT's competitors is 2.83, providing a benchmark for relative valuation. Fulgent Genetics Inc Corp (FLGT) exhibits a P/S ratio of 2.27, which is -19.91% above the industry average. Given its robust revenue growth of 17.18%, this premium appears unsustainable.
What is the current P/B ratio for Fulgent Genetics Inc (FLGT) as of Jan 10 2026?
As of Jan 10 2026, Fulgent Genetics Inc (FLGT) has a P/B ratio of 0.70. This indicates that the market values FLGT at 0.70 times its book value.
What is the current FCF Yield for Fulgent Genetics Inc (FLGT) as of Jan 10 2026?
As of Jan 10 2026, Fulgent Genetics Inc (FLGT) has a FCF Yield of -2.51%. This means that for every dollar of Fulgent Genetics Inc’s market capitalization, the company generates -2.51 cents in free cash flow.
What is the current Forward P/E ratio for Fulgent Genetics Inc (FLGT) as of Jan 10 2026?
As of Jan 10 2026, Fulgent Genetics Inc (FLGT) has a Forward P/E ratio of -128.21. This means the market is willing to pay $-128.21 for every dollar of Fulgent Genetics Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Fulgent Genetics Inc (FLGT) as of Jan 10 2026?
As of Jan 10 2026, Fulgent Genetics Inc (FLGT) has a Forward P/S ratio of 2.27. This means the market is valuing FLGT at $2.27 for every dollar of expected revenue over the next 12 months.